Oliver Klein

Dr. Oliver Klein

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2018 in Proteomics – Clinical Applications
Verified
Journal Article
Closed access
PDF file
OKOliver Klein
Oliver Klein
FKFrederic Kanter
Frederic Kanter
HKHagen Kulbe
Hagen Kulbe
PJPaul Jank
Paul Jank
CDCarsten Denkert
Carsten Denkert
ETEliane Tabea Taube
Eliane Tabea Taube

23 July 2014 in Proteomics
Verified
Journal Article
Closed access
PDF file
OKOliver Klein
Oliver Klein
KSKristin Strohschein
Kristin Strohschein
GNGrit Nebrich
Grit Nebrich
JOJanina Oetjen
Janina Oetjen
DTDennis Trede
Dennis Trede
TWTobias Winkler
Tobias Winkler

Verified
Journal Article
Open access
PDF file
MBMatthias Becker
Matthias Becker
JMJanita A. Maring
Janita A. Maring
MSMaria Schneider
Maria Schneider
AMAaron Xerach Herrera Martin
Aaron Xerach Herrera Martin
MSMartina Seifert
Martina Seifert
Christof StammChristof Stamm
Christof Stamm
There is a growing need for scaffold material with tissue-specific bioactivity for use in regenerative medicine, tissue engineering, and for surgical repair of structural defects. We developed a novel composite biomaterial by processing human cardiac extracellular matrix (ECM) into a hydrogel and combining it with cell-free amniotic membrane via a dry-coating procedure. Cardiac biocompatibility and immunogenicity were tested in vitro using human cardiac fibroblasts, epicardial progenitor cells, murine HL-1 cells, and human immune cells derived from buffy coat. Processing of the ECM preserved important matrix proteins as demonstrated by mass spectrometry. ECM coating did not alter the mechanical characteristics of decellularized amniotic membrane but did cause a clear increase in adhesion capacity, cell proliferation and viability. Activated monocytes secreted less pro-inflammatory cytokines, and both macrophage polarization towards the pro-inflammatory M1 type and T cell proliferation were prevented. We conclude that the incorporation of human cardiac ECM hydrogel shifts and enhances the bioactivity of decellularized amniotic membrane, facilitating its use in future cardiac applications.

22 March 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
SHSarah Hochmann
Sarah Hochmann
KOKristy Ou
Kristy Ou
RPRodolphe William Poupardin
Rodolphe William Poupardin
MMMichaela Mittermeir
Michaela Mittermeir
MTMartin Textor
Martin Textor
DSDirk Strunk
Dirk Strunk
Multipotent stromal cells are considered attractive sources for cell therapy and tissue engineering. Despite numerous experimental and clinical studies, broad application of stromal cell therapeutics is not yet emerging. A major challenge is the functional diversity of available cell sources. Here, we investigated the regenerative potential of clinically relevant human stromal cells from bone marrow (BMSCs), white adipose tissue, and umbilical cord compared with mature chondrocytes and skin fibroblasts in vitro and in vivo. Although all stromal cell types could express transcription factors related to endochondral ossification, only BMSCs formed cartilage discs in vitro that fully regenerated critical-size femoral defects after transplantation into mice. We identified cell type–specific epigenetic landscapes as the underlying molecular mechanism controlling transcriptional stromal differentiation networks. Binding sites of commonly expressed transcription factors in the enhancer and promoter regions of ossification-related genes, including Runt and bZIP families, were accessible only in BMSCs but not in extraskeletal stromal cells. This suggests an epigenetically predetermined differentiation potential depending on cell origin that allows common transcription factors to trigger distinct organ-specific transcriptional programs, facilitating forward selection of regeneration-competent cell sources. Last, we demonstrate that viable human BMSCs initiated defect healing through the secretion of osteopontin and contributed to transient mineralized bone hard callus formation after transplantation into immunodeficient mice, which was eventually replaced by murine recipient bone during final tissue remodeling.

1 October 2020 in Biomaterials
Verified
Journal Article
Closed access
ADAssal Daneshgar
Assal Daneshgar
OKOliver Klein
Oliver Klein
GNGrit Nebrich
Grit Nebrich
MWMarie Weinhart
Marie Weinhart
PTPeter Tang
Peter Tang
KHKarl Herbert Hillebrandt
Karl Herbert Hillebrandt

17 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
MGMarta Grzeski
Marta Grzeski
ETEliane Tabea Taube
Eliane Tabea Taube
IBIoana Braicu
Ioana Braicu
JSJalid Sehouli
Jalid Sehouli
VBVéronique Blanchard
Véronique Blanchard
OKOliver Klein
Oliver Klein
The particularly high mortality of epithelial ovarian cancer (EOC) is in part linked to limited understanding of its molecular signatures. Although there are data available on in situ N-glycosylation in EOC tissue, previous studies focused primarily on neutral N-glycan species and, hence, still little is known regarding EOC tissue-specific sialylation. In this proof-of-concept study, we implemented MALDI mass spectrometry imaging (MALDI-MSI) in combination with sialic acid derivatization to simultaneously investigate neutral and sialylated N-glycans in formalin-fixed paraffin-embedded tissue microarray specimens of less common EOC histotypes and non-malignant borderline ovarian tumor (BOT). The applied protocol allowed detecting over 50 m/z species, many of which showed differential tissue distribution. Most importantly, it could be demonstrated that α2,6- and α2,3-sialylated N-glycans are enriched in tissue regions corresponding to tumor and adjacent tumor-stroma, respectively. Interestingly, analogous N-glycosylation patterns were observed in tissue cores of BOT, suggesting that regio-specific N-glycan distribution might occur already in non-malignant ovarian pathologies. All in all, our data provide proof that the combination of MALDI-MSI and sialic acid derivatization is suitable for delineating regio-specific N-glycan distribution in EOC and BOT tissues and might serve as a promising strategy for future glycosylation-based biomarker discovery studies.